Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer

References

• BrodyH. Colorectal cancer. Nature. 2015;521(7551):S1. doi:10.1038/521S1a25970450
   PubMed Web of Science ®Google Scholar
• GuptaS, ProvenzaleD, RegenbogenSE, et al. NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 3.2017. J Natl Compr Canc Netw. 2017;15(12):1465–1475. doi:10.6004/jnccn.2017.017629223984
   PubMed Web of Science ®Google Scholar
• WilliamsCD, GradyWM, ZulligLL. Use of NCCN guidelines, other guidelines, and biomarkers for colorectal cancer screening. J Natl Compr Canc Netw. 2016;14(11):1479–1485. doi:10.6004/jnccn.2016.015427799515
   PubMed Web of Science ®Google Scholar
• FakihMG. Metastatic colorectal cancer: current state and future directions. J Clin Oncol. 2015;33(16):1809–1824. doi:10.1200/JCO.2014.59.763325918280
   PubMed Web of Science ®Google Scholar
• PedrosaL, EspositoF, ThomsonTM, MaurelJ. The tumor microenvironment in colorectal cancer therapy. Cancers (Basel). 2019;11:8. doi:10.3390/cancers11081172
   Web of Science ®Google Scholar
• FujitaK, KubotaY, IshidaH, SasakiY. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol. 2015;21(43):12234–12248. doi:10.3748/wjg.v21.i43.1223426604633
   PubMed Web of Science ®Google Scholar
• LiuD, LiJ, GaoJ, LiY, YangR, ShenL. Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis. BMC Cancer. 2017;17(1):437. doi:10.1186/s12885-017-3406-228637434
   PubMed Web of Science ®Google Scholar
• BartoşA, BartoşD, SzaboB, et al. Recent achievements in colorectal cancer diagnostic and therapy by the use of nanoparticles. Drug Metab Rev. 2016;48(1):27–46. doi:10.3109/03602532.2015.113005226828283
   PubMed Web of Science ®Google Scholar
• DongZ, CuiMY, PengZ, et al. Nanoparticles for colorectal cancer targeted drug delivery and MR imaging: current situation and perspectives. Curr Cancer Drug Targets. 2016;16(6):536–550. doi:10.2174/156800961666615113021444226632434
   PubMed Web of Science ®Google Scholar
• CisternaBA, KamalyN, ChoiWI, TavakkoliA, FarokhzadOC, VilosC. Targeted nanoparticles for colorectal cancer. Nanomedicine (Lond). 2016;11(18):2443–2456. doi:10.2217/nnm-2016-019427529192
   PubMed Web of Science ®Google Scholar
• SongY, CaiH, YinT, et al. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment. Int J Nanomedicine. 2018;13:1585–1600. doi:10.2147/IJN29588586
   PubMed Web of Science ®Google Scholar
• JianYS, ChenCW, LinCA, et al. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo. Int J Nanomedicine. 2017;12:2315–2333. doi:10.2147/IJN.S12084728392690
   PubMed Web of Science ®Google Scholar
• TeoPY, ChengW, HedrickJL, YangYY. Co-delivery of drugs and plasmid DNA for cancer therapy. Adv Drug Deliv Rev. 2016;98:41–63. doi:10.1016/j.addr.2015.10.01426529199
   PubMed Web of Science ®Google Scholar
• PengZ, WangC, FangE, LuX, WangG, TongQ. Co-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapy. PLoS One. 2014;9(3):e92924. doi:10.1371/journal.pone.009292424675979
   PubMed Web of Science ®Google Scholar
• HanY, ZhangP, ChenY, SunJ, KongF. Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy. Int J Mol Med. 2014;34(1):191–196. doi:10.3892/ijmm.2014.177024804644
   PubMed Web of Science ®Google Scholar
• LiuC, LiuF, FengL, LiM, ZhangJ, ZhangN. The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. Biomaterials. 2013;34(10):2547–2564. doi:10.1016/j.biomaterials.2012.12.03823332321
   PubMed Web of Science ®Google Scholar
• ZhaoD, ZhuoRX, ChengSX. Modification of calcium carbonate based gene and drug delivery systems by a cell-penetrating peptide. Mol Biosyst. 2012;8(12):3288–3294. doi:10.1039/c2mb25233c23086311
   PubMedGoogle Scholar
• ZhaoK, LiD, ShiC, et al. Biodegradable polymeric nanoparticles as the delivery carrier for drug. Curr Drug Deliv. 2016;13(4):494–499. doi:10.2174/15672018130416052100460927230997
   PubMed Web of Science ®Google Scholar
• BanerjeeK, GautamSK, KshirsagarP, et al. Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells. Genes Cancer. 2019;10(3–4):52–62. doi:10.18632/genesandcancer.18931258832
   PubMedGoogle Scholar
• HuJ, ShengY, ShiJ, YuB, YuZ, LiaoG. Long circulating polymeric nanoparticles for gene/drug delivery. Curr Drug Metab. 2018;19(9):723–738. doi:10.2174/138920021966617120712064329219050
   PubMed Web of Science ®Google Scholar
• WangZ, WeiY, FangG, et al. Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers. Drug Des Devel Ther. 2018;12:3171–3180. doi:10.2147/DDDT.S175614
   PubMed Web of Science ®Google Scholar
• GandhiNS, TekadeRK, ChouguleMB. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. J Control Release. 2014;28(194):238–256. doi:10.1016/j.jconrel.2014.09.001
   Web of Science ®Google Scholar
• HadinotoK, SundaresanA, CheowWS. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013;85(3):427–443. doi:10.1016/j.ejpb.2013.07.00223872180
   PubMed Web of Science ®Google Scholar
• ZhangL, ZhuD, DongX, et al. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Int J Nanomedicine. 2015;10:2101–2114. doi:10.2147/IJN.S7766725844039
   PubMed Web of Science ®Google Scholar
• ZhangL, CuiH. HAase-sensitive dual-targeting irinotecan liposomes enhance the therapeutic efficacy of lung cancer in animals. Nanotheranostics. 2018;2(3):280–294. doi:10.7150/ntno.2555529977740
   PubMedGoogle Scholar
• YuW, LiuC, LiuY, ZhangN, XuW. Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res. 2010;27(8):1584–1596. doi:10.1007/s11095-010-0149-z20422265
   PubMed Web of Science ®Google Scholar
• LiS, WangL, LiN, LiuY, SuH. Combination lung cancer chemotherapy: design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin. Biomed Pharmacother. 2017;95:548–555. doi:10.1016/j.biopha.2017.08.09028869892
   PubMed Web of Science ®Google Scholar
• YuW, LiuC, YeJ, ZouW, ZhangN, XuW. Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery. Nanotechnology. 2009;20(21):215102. doi:10.1088/0957-4484/20/21/21510219423923
   PubMed Web of Science ®Google Scholar
• GaoZ, LiZ, YanJ, WangP. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy. Drug Des Devel Ther. 2017;11:2595–2604. doi:10.2147/DDDT
   PubMed Web of Science ®Google Scholar
• WangL, LiuZ, LiuD, LiuC, JuanZ, ZhangN. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Int J Pharm. 2011;413(1–2):194–201. doi:10.1016/j.ijpharm.2011.04.02321540085
   PubMed Web of Science ®Google Scholar
• LiP, LiuD, MiaoL, et al. A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery. Int J Nanomedicine. 2012;7:925–939. doi:10.2147/IJN.S2695522393290
   PubMed Web of Science ®Google Scholar
• LiuL, CaoF, LiuX, et al. Hyaluronic acid-modified cationic lipid-PLGA hybrid nanoparticles as a nanovaccine induce robust humoral and cellular immune responses. ACS Appl Mater Interfaces. 2016;8(19):11969–11979. doi:10.1021/acsami.6b0113527088457
   PubMed Web of Science ®Google Scholar
• PramanikN, RanganathanS, RaoS, et al. A composite of hyaluronic acid-modified graphene oxide and iron oxide nanoparticles for targeted drug delivery and magnetothermal therapy. ACS Omega. 2019;4(5):9284–9293. doi:10.1021/acsomega.9b0087031460017
   PubMed Web of Science ®Google Scholar
• LeeJE, YinY, LimSY, et al. Enhanced transfection of human mesenchymal stem cells using a hyaluronic acid/calcium phosphate hybrid gene delivery system. Polymers (Basel). 2019;11:5. doi:10.3390/polym11050798
   Web of Science ®Google Scholar
• FangZ, LiX, XuZ, et al. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe(3)O(4) nanoparticles for targeted drug delivery. Int J Nanomedicine. 2019;14:5785–5797. doi:10.2147/IJN.S21397431440047
   PubMed Web of Science ®Google Scholar
• ZhangR, RuY, GaoY, LiJ, MaoS. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer. Drug Des Devel Ther. 2017;11:2631–2642. doi:10.2147/DDDT
   PubMed Web of Science ®Google Scholar
• ZhengG, ZhengM, YangB, FuH, LiY. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo. Biomed Pharmacother. 2019;116:109006. doi:10.1016/j.biopha.2019.10900631152925
   PubMed Web of Science ®Google Scholar
• CuiT, ZhangS, SunH. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment. Oncol Rep. 2017;37(2):1253–1260. doi:10.3892/or.2017.534528075466
   PubMed Web of Science ®Google Scholar
• MaP, LiT, XingH, et al. Local anesthetic effects of bupivacaine loaded lipid-polymer hybrid nanoparticles: in vitro and in vivo evaluation. Biomed Pharmacother. 2017;89:689–695. doi:10.1016/j.biopha.2017.01.17528267672
   PubMed Web of Science ®Google Scholar
• XuG, ChenY, ShanR, WuX, ChenL. Transferrin and tocopheryl-polyethylene glycol-succinate dual ligands decorated, cisplatin loaded nano-sized system for the treatment of lung cancer. Biomed Pharmacother. 2018;99:354–362. doi:10.1016/j.biopha.2018.01.06229358128
   PubMed Web of Science ®Google Scholar
• SunY, LiX, ZhangL, et al. Cell permeable NBD peptide-modified liposomes by hyaluronic acid coating for the synergistic targeted therapy of metastatic inflammatory breast cancer. Mol Pharm. 2019;16(3):1140–1155. doi:10.1021/acs.molpharmaceut.8b0112330668131
   PubMed Web of Science ®Google Scholar
• TranTH, ChoiJY, RamasamyT, et al. Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells. Carbohydr Polym. 2014;114:407–415. doi:10.1016/j.carbpol.2014.08.02625263908
   PubMed Web of Science ®Google Scholar
• WangH, SunG, ZhangZ, OuY. Transcription activator, hyaluronic acid and tocopheryl succinate multi-functionalized novel lipid carriers encapsulating etoposide for lymphoma therapy. Biomed Pharmacother. 2017;91:241–250. doi:10.1016/j.biopha.2017.04.10428460227
   PubMed Web of Science ®Google Scholar
• HuCM, KaushalS, Tran caoHS, et al. Half-antibody functionalized lipid−polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. Mol Pharm. 2010;7(3):914–920. doi:10.1021/mp900316a20394436
   PubMed Web of Science ®Google Scholar
• ChanJM, ZhangL, YuetKP, et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials. 2009;30:1627–1634. doi:10.1016/j.biomaterials.2008.12.01319111339
   PubMed Web of Science ®Google Scholar
• KobayashiH, TurkbeyB, WatanabeR, ChoykePL. Cancer drug delivery: considerations in the rational design of nanosized bioconjugates. Bioconjug Chem. 2014;25(12):2093–2100. doi:10.1021/bc500481x25385142
   PubMed Web of Science ®Google Scholar
• DengT, PengY, ZhangR, et al. Water-solubilizing hydrophobic ZnAgInSe/ZnS QDs with tumor-targeted cRGD-sulfobetaine-PIMA-histamine ligands via a self-assembly strategy for bioimaging. ACS Appl Mater Interfaces. 2017;9(13):11405–11414. doi:10.1021/acsami.6b1663928293947
   PubMed Web of Science ®Google Scholar
• DateT, NimbalkarV, KamatJ, MittalA, MahatoRI, ChitkaraD. Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics. J Control Release. 2018;271:60–73. doi:10.1016/j.jconrel.2017.12.01629273320
   PubMed Web of Science ®Google Scholar